Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-014190
Filing Date
2018-05-29
Accepted
2018-05-29 06:52:13
Documents
1
Period of Report
2018-05-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3381
  Complete submission text file 0000899243-18-014190.txt   4688
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Issuer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address TBD TBD TBD CA 99999
Business Address
ASADORIAN RAFFI (Reporting) CIK: 0001628970 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35068 | Film No.: 18862909